Cardiac Biomarkers Market Size, Share, Upcoming Trends, Key Players, Analysis, and Forecast 2021-2026

Cardiac Biomarkers Market Size, Share, Upcoming Trends, Key Players, Analysis, and Forecast 2021-2026

As per the latest report by IMARC Group, titled “Cardiac Biomarkers Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026”, the global cardiac biomarkers market reached a value of US$ 8.2 Billion in 2020. Looking forward, IMARC Group expects the global cardiac biomarkers market to exhibit moderate growth during 2021-2026. Cardiac biomarkers refer to endogenous substances including enzymes, hormones and proteins, which are released into the bloodstream when the heart muscles are damaged, or the organ is stressed. Also known as cardiac enzymes, these substances include myoglobin, troponin, creatine kinase and ischemia-modified albumin. The measurement of these markers aids in diagnosing conditions associated with insufficient blood flow to the heart. They evaluate the heart’s function and assist in the early diagnosis of certain diseases. They are also used in the risk stratification of patients with chest pain and cardiovascular diseases (CVDs), such as suspected acute coronary syndrome (ACS) or myocardial infarction (MI). Physicians now widely prefer cardiac biomarker measurements over cardiac imaging diagnosis as these procedures are relatively simpler, cost-effective, and offer highly accurate results.

We are regularly tracking the direct effect of COVID-19 on the market, along with the indirect influence of associated industries. These observations will be integrated into the report.

Request Free Sample Report:

Global Cardiac Biomarkers Market Trends:

Changing lifestyles, hectic schedules and shifting dietary patterns have resulted in the frequent occurrence of chronic diseases such as diabetes and CVDs. This, along with growing awareness among the majority of the population regarding the importance of early diagnosis of these chronic diseases, is driving the demand for cardiac biomarkers. Also, quicker results and easy availability of point of care (POC) cardiac testing kits are further providing a thrust to the market growth. Furthermore, manufacturers are continually engaging in research and development (R&D) activities to develop technologically advanced product variants such as multi-assay biomarkers. Other factors creating a positive outlook for the market include rapid urbanization, rising disposable income, and favorable government initiative for making quality healthcare services accessible to all.

Explore Full Report with TOC & List of Figure:

Key Market Segmentation:              

Competitive Landscape:

The competitive landscape of the market has also been analyzed, with some of the key players operating in the market being Abbott Laboratories, Alere Inc., Beckman Coulter, Becton, Dickinson And Co., Biomerieux, Bio-Rad Laboratories, Randox Laboratories, Roche Diagnostics Corporation, Siemens Healthcare and Thermo Fisher Scientific.

  • On the basis of the type, the market has been divided into troponins (T and I), myocardial muscle creatine kinase (CK-MB), myoglobin, brain natriuretic peptide (BNPs) or NT-proBNP, ischemia modified albumin (IMA) and others.
  • Based on the location of testing, the market has been bifurcated into laboratory testing and point of care testing, wherein laboratory testing exhibits a clear dominance in the market.
  • On the basis of the application, the market has been categorized into myocardial infarction, congestive heart failure, acute coronary syndrome, atherosclerosis and others. Amongst these, myocardial infarction accounts for the majority of the total market share.
  • On the geographical front, North America holds the leading position in the market. Other major regions include Asia Pacific, Europe, Middle East and Africa, and Latin America.

Key highlights of the Report:

  • Market Performance
  • Market Outlook
  • Porter’s Five Forces Analysis
  • Market Drivers and Success Factors
  • SWOT Analysis
  • Value Chain
  • Comprehensive Mapping of the Competitive Landscape

If you need specific information that is not currently within the scope of the report, we can provide it to you as a part of the customization.

About Us

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact US

30 N Gould St, Ste R
Sheridan, WY (Wyoming) 82801 USA
Email: [email protected]
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800

Other Reports By IMARC Group: